Market leader in peptide API manufacturing and services
PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) supporting pharmaceutical and biotech companies in the development and manufacturing of proprietary and generic active pharmaceutical ingredients (API).
PolyPeptide provides market update
12 Jul 2022 - Media Release – ad hoc announcement pursuant to Art. 53 LR Baar, 12 July 2022 – PolyPeptide Group AG (PolyPeptide), a global leader in peptide and […]
Read morePolyPeptide wins Malmö Life Science Business Award
28 Jun 2022 - Malmö, 21 June 2022 We are proud of our site in Malmö, Sweden, for winning the Life Science Business Award of the city (Malmö Näringslivspris Life […]
Read more